Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 687

1.

[Clinical implications of edoxaban in the current scenario of oral anticoagulants].

De Caterina R.

G Ital Cardiol (Rome). 2014 Dec;15(12):27-9. doi: 10.1714/1744.18990. Italian.

PMID:
25621575
[PubMed - in process]
2.

Acute pulmonary embolism: risk assessment, risk stratification and treatment options.

Piovella F, Iosub DI.

Clin Respir J. 2015 Jan 26. doi: 10.1111/crj.12264. [Epub ahead of print]

PMID:
25619266
[PubMed - as supplied by publisher]
3.

Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.

Stöllberger C, Finsterer J.

Herz. 2015 Jan 25. [Epub ahead of print]

PMID:
25616425
[PubMed - as supplied by publisher]
4.

Identification and Management of Noncompliance in Atrial Fibrillation Patients Receiving Dabigatran: The Role of a Drug Monitor.

Hu YF, Liao JN, Chern CM, Weng CH, Lin YJ, Chang SL, Wu CH, Sung SH, Wang KL, Lu TM, Chao TF, Lo LW, Chung FP, Hsu LC, Chen SA.

Pacing Clin Electrophysiol. 2015 Jan 20. doi: 10.1111/pace.12575. [Epub ahead of print]

PMID:
25601592
[PubMed - as supplied by publisher]
5.

Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis.

Schmohl M, Gansser D, Moschetti V, Stangier J.

Thromb Res. 2015 Jan 2. pii: S0049-3848(14)00690-2. doi: 10.1016/j.thromres.2014.12.021. [Epub ahead of print]

PMID:
25600440
[PubMed - as supplied by publisher]
6.

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study.

Gorst-Rasmussen A, Skjøth F, Larsen TB, Rasmussen LH, Lip GY, Lane DA.

J Thromb Haemost. 2015 Jan 16. doi: 10.1111/jth.12845. [Epub ahead of print]

PMID:
25594442
[PubMed - as supplied by publisher]
7.

Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.

Honickel M, Treutler S, van Ryn J, Tillmann S, Rossaint R, Grottke O.

Thromb Haemost. 2015 Jan 8;113(4). [Epub ahead of print]

PMID:
25567155
[PubMed - as supplied by publisher]
8.

Generation of an anti-dabigatran monoclonal antibody and its employment in a highly sensitive and specific enzyme-linked immunosorbent assay for serum dabigatran.

Oiso S, Morinaga O, Goroku T, Uto T, Shoyama Y, Kariyazono H.

Ther Drug Monit. 2015 Jan 6. [Epub ahead of print]

PMID:
25565675
[PubMed - as supplied by publisher]
9.

Left atrial appendage thrombus with resulting stroke post-RF ablation for atrial fibrillation in a patient on dabigatran.

Lobo R, McCann C, Hussaini A, Meany TB, Kiernan TJ.

Ir Med J. 2014 Nov-Dec;107(10):329-30.

PMID:
25551903
[PubMed - indexed for MEDLINE]
10.

[Fatal bleeding diarrhoea during dabigatran etexilate therapy.]

Nyby S, Hennes O.

Ugeskr Laeger. 2014 Dec 15;176(51). pii: V09140482. Danish.

PMID:
25534224
[PubMed - as supplied by publisher]
11.

Evaluation of dabigatran for appropriateness of use and bleeding events in a community hospital setting.

Armbruster AL, Buehler KS, Min SH, Riley M, Daly MW.

Am Health Drug Benefits. 2014 Oct;7(7):376-84.

PMID:
25525494
[PubMed]
Free PMC Article
12.

Laboratory Assessment of the Anticoagulant Activity of Dabigatran.

Kyriakou E, Ikonomidis I, Stylos D, Bonovas S, Papadakis I, Nikolopoulos GK, Kokoris S, Kalantzis D, Economopoulou C, Kopterides P, Lekakis J, Tsantes AE.

Clin Appl Thromb Hemost. 2014 Dec 18. pii: 1076029614564209. [Epub ahead of print]

PMID:
25525048
[PubMed - as supplied by publisher]
13.

Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.

Douxfils J, Lessire S, Dincq AS, Hjemdahl P, Rönquist-Nii Y, Pohanka A, Gourdin M, Chatelain B, Dogné JM, Mullier F.

Thromb Haemost. 2014 Dec 18;113(3). [Epub ahead of print]

PMID:
25519251
[PubMed - as supplied by publisher]
14.

[Laboratory assessment of haemostatic parameters in patients taking a direct thrombin inhibitor.]

Beliavskaia OO, Vavilova TV.

Angiol Sosud Khir. 2014;20(4):37-41. Russian.

PMID:
25490355
[PubMed - as supplied by publisher]
15.

Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of dabigatran etexilate, intermediate metabolite and dabigatran in 50μL rat plasma and its application to pharmacokinetic study.

Li J, Fang J, Zhong F, Li W, Tang Y, Xu Y, Mao S, Fan G.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 8;973C:110-119. doi: 10.1016/j.jchromb.2014.09.025. [Epub ahead of print]

PMID:
25464103
[PubMed - as supplied by publisher]
16.

RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy.

Calkins H, Gerstenfeld EP, Schilling R, Verma A, Willems S; RE-CIRCUIT Study Steering Committee.

Am J Cardiol. 2015 Jan 1;115(1):154-5. doi: 10.1016/j.amjcard.2014.10.002. Epub 2014 Oct 16. No abstract available.

PMID:
25456859
[PubMed - in process]
17.

Enhanced Elimination of Dabigatran Through Extracorporeal Methods.

Awad NI, Brunetti L, Juurlink DN.

J Med Toxicol. 2014 Dec 2. [Epub ahead of print]

PMID:
25448250
[PubMed - as supplied by publisher]
18.

Does Dabigatran Increase the Risk of Delayed Hematoma Expansion in a Rat Model of Collagenase-Induced Intracerebral Hemorrhage?

Tanoue S, Inamasu J, Yamada M, Toyama H, Hirose Y.

J Stroke Cerebrovasc Dis. 2014 Nov 25. pii: S1052-3057(14)00466-2. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.010. [Epub ahead of print]

PMID:
25444028
[PubMed - as supplied by publisher]
19.

Incidence, mortality, and risk factors for oral anticoagulant-associated intracranial hemorrhage in patients with atrial fibrillation.

Grysiewicz R, Gorelick PB.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2479-88. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.031. Epub 2014 Oct 29.

PMID:
25440361
[PubMed - in process]
20.

Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence.

Zalpour A, Oo TH.

Drug Des Devel Ther. 2014 Nov 5;8:2181-91. doi: 10.2147/DDDT.S51006. eCollection 2014.

PMID:
25395835
[PubMed - in process]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk